CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+29.24%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$9.46B
AUM Growth
+$433M
(+4.8%)
Cap. Flow
-$87.8M
Cap. Flow
% of AUM
-0.93%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
907
New
103
Increased
255
Reduced
393
Closed
103
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$59.9M |
| 2 |
Merck
MRK
|
$49.9M |
| 3 |
Danaher
DHR
|
$49.5M |
| 4 |
JD.com
JD
|
$44.8M |
| 5 |
Thermo Fisher Scientific
TMO
|
$40.8M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$114M |
| 2 |
Alibaba
BABA
|
$102M |
| 3 |
Salesforce
CRM
|
$58.9M |
| 4 |
Bristol-Myers Squibb
BMY
|
$58.4M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$52M |
Sector Composition
| 1 | Healthcare | 34.68% |
| 2 | Technology | 20.98% |
| 3 | Consumer Discretionary | 8.92% |
| 4 | Financials | 8.6% |
| 5 | Communication Services | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
176
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $12.6M | 0.13% |
172,799
-16,000
| -8% | -$1.17M |
|
177
Campbell Soup
CPB
$10.1B
| $12.6M | 0.13% |
254,218
+104,480
| +70% | +$5.19M |
|
|
MRTX
178
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $12.6M | 0.13% |
110,061
+10,733
| +11% | +$1.23M |
|
179
McDonald's
MCD
$224B
| $12.6M | 0.13% |
68,056
-20,181
| -23% | -$3.72M |
|
180
Charter Communications
CHTR
$35.6B
| $12.6M | 0.13% |
24,607
+13,006
| +112% | +$6.63M |
|
181
Zymeworks
ZYME
$1.11B
| $12.4M | 0.13% |
344,484
+112,215
| +48% | +$4.05M |
|
182
Arvinas
ARVN
$597M
| $12.2M | 0.13% |
364,285
+91,462
| +34% | +$3.07M |
|
183
Advanced Drainage Systems
WMS
$11.4B
| $12.2M | 0.13% |
247,015
+117,262
| +90% | +$5.79M |
|
184
Cigna
CI
$82B
| $12.2M | 0.13% |
64,949
-7,110
| -10% | -$1.33M |
|
185
Becton Dickinson
BDX
$55B
| $12M | 0.13% |
51,265
-13,523
| -21% | -$3.16M |
|
186
Coherus Oncology, Inc. Common Stock
CHRS
$151M
| $11.9M | 0.13% |
666,372
+328,577
| +97% | +$5.87M |
|
|
CNST
187
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $11.9M | 0.13% |
394,652
+270,868
| +219% | +$8.14M |
|
|
HOLI
188
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $11.9M | 0.13% |
891,448
+40,929
| +5% | +$544K |
|
189
Church & Dwight Co
CHD
$23.3B
| $11.7M | 0.12% |
151,666
+65,283
| +76% | +$5.05M |
|
190
CEVA Inc
CEVA
$545M
| $11.7M | 0.12% |
311,894
+14,460
| +5% | +$541K |
|
191
TJX Companies
TJX
$155B
| $11.7M | 0.12% |
230,717
-238,824
| -51% | -$12.1M |
|
192
Madrigal Pharmaceuticals
MDGL
$9.67B
| $11.6M | 0.12% |
102,584
+61,634
| +151% | +$6.98M |
|
193
Acadia Pharmaceuticals
ACAD
$4.26B
| $11.6M | 0.12% |
239,000
+159,000
| +199% | +$7.71M |
|
194
Fortinet
FTNT
$60.5B
| $11.5M | 0.12% |
419,915
-248,085
| -37% | -$6.81M |
|
195
HDFC Bank
HDB
$180B
| $11.5M | 0.12% |
253,331
+237,331
| +1,483% | +$10.8M |
|
196
Ambarella
AMBA
$3.51B
| $11.3M | 0.12% |
247,613
+73,290
| +42% | +$3.36M |
|
197
CVS Health
CVS
$94.1B
| $11.3M | 0.12% |
173,377
+4,959
| +3% | +$322K |
|
198
Amicus Therapeutics
FOLD
$2.51B
| $11.2M | 0.12% |
741,588
-187,912
| -20% | -$2.83M |
|
199
General Mills
GIS
$26.9B
| $11.2M | 0.12% |
181,135
+53,276
| +42% | +$3.28M |
|
200
Vulcan Materials
VMC
$38.8B
| $11.1M | 0.12% |
95,902
+83,415
| +668% | +$9.66M |
|